 Clinical Oncology News | Adjuvant Therapy Fails for High-Risk Soft Tissue Sarcoma Clinical Oncology News In most oncology patients, one can get cyclophosphamide-doxorubicin or R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) anywhere in the world the same way, but in STS, there still is no standard method of administration. |
